Search this website. You can use fund codes to locate specific funds

CORONAVIRUS

Spotlight

No posts matching your criteria
Can coronavirus vaccines be distributed equitably? With pharmaceutical companies now rolling out effective vaccines for Covid-19, how do we ensure these are distributed fairly? 14/12/2020 - Sarah Swartz

Stewardship throughout the pandemic

No posts matching your criteria
Can coronavirus vaccines be distributed equitably? With pharmaceutical companies now rolling out effective vaccines for Covid-19, how do we ensure these are distributed fairly? 14/12/2020 - Sarah Swartz
The coronavirus and the race for a vaccine With the coronavirus pandemic set to continue without an effective and widely-available vaccine, all eyes are on the pharmaceutical sector. 23/09/2020 - Katie Frame
Antimicrobial resistance and the challenge for pharmaceutical companies A lack of research and development into new antibiotic classes compounds the serious threat that antimicrobial resistance poses to public health. 28/08/2020
Fighting infection – animal welfare and antimicrobial resistance The coronavirus has highlighted the importance of being well prepared to respond to emerging global health threats. 03/08/2020 - Dr Emma Berntman
Climate change and infectious diseases As we manage through the coronavirus pandemic, we must not lose sight of the systemic risk posed by the climate crisis. 05/06/2020 - Nicholas Spooner
The coronavirus and our relationship with nature In this series, we will explore the links between infectious diseases, environmental issues and social sustainability, alongside the role of investors and companies. In part one, Sonya Likhtman looks at how the destruction of ecosystems can increase the risk of pandemics. 04/05/2020 - Sonya Likhtman
Protecting biodiversity through sustainable land use How do deforestation and industrialised agriculture contribute to biodiversity loss, and why should companies ensure sustainable land use throughout their value chains? 02/07/2020 - Sonya Likhtman

Safely reopening our offices'

We value the health and well-being of our people and have complied with the UK government's guidance on managing the risk of coronavirus. As a business, we have:

  • Conducted formal coronavirus risk assessments of our offices
  • Advised that all colleagues who are able to work from home continue to do so
  • Established and communicated clear guidelines for colleagues who choose to return to our offices because they are unable to perform their role effectively at home
  • Taken measures to manage the transmission risk for our colleagues so far as is reasonably practicable, in line with UK government guidelines

Key pieces

No posts matching your criteria
EOS
Stewardship during a crisis: lessons from the pandemic Dr Hans-Christoph Hirt, head of EOS, reflects on the pandemic and the stewardship lessons for companies and investors. 15/03/2021 - Dr. Hans-Christoph Hirt
Equities
Hidden factors: exploring equity market behaviour in 2020 Looking at the extreme market events of the past 12 months can provide some valuable insights for investors. 11/01/2021 - Lewis Grant
EOS
Can coronavirus vaccines be distributed equitably? With pharmaceutical companies now rolling out effective vaccines for Covid-19, how do we ensure these are distributed fairly? 14/12/2020 - Sarah Swartz
Equities
ESG investing: how Covid-19 accelerated the social awakening We examine how ESG factors have behaved during the ongoing coronavirus pandemic. 09/12/2020 - Lewis Grant
Equities
The Meeting Room Webcast: Asia ex-Japan, November 2020 Listen to the latest Federated Hermes Meeting Room: Virtual Portfolio Briefing on Asia ex-Japan 13/11/2020 - Jonathan Pines
Equities
The coronavirus and its impact on SDG 8 How can the actions of companies affect SDG 8? Has the coronavirus interrupted progress towards this goal? 12/11/2020 - Aoifinn Devitt
Fixed Income
Credit: Industry Insights (energy transition) Fuelling the energy transition: how the oil and gas industry is preparing for a changing world 03/11/2020 - Audra Delport
Equities
The Meeting Room Webcast: Global Emerging Markets, October 2020 As we navigate the ever-changing landscape of the coronavirus, the Global Emerging Markets team reflect on recent performance, and discuss the outlook for Global Emerging Markets from both a market and portfolio positioning perspective. 27/10/2020 - Gary Greenberg
Fixed Income
Credit: Industry Insights (European telecoms) What is driving the acceleration of M&A activity in the European telecoms sector? 20/10/2020 - Joe Howes
Fixed Income
Credit: Industry Insights (hospital operators) With second-quarter earnings wrapped up for US retailers, all eyes are now on the holiday season. How will retailers fare in the second half of the year? 05/10/2020 - Robin Usson
Fixed Income
Credit: Industry Insights (retail) With second-quarter earnings wrapped up for US retailers, all eyes are now on the holiday season. 21/09/2020 - Ilana Elbim
Coronavirus
Impact investing in the coronavirus era Has the coronavirus pandemic resulted in a paradigm shift for responsible investment strategies? 18/09/2020 - Aoifinn Devitt
View more